ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Dinner To Raise Funds For NIH Children’s Inn

March 31, 1989

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Frederick RFP Held Up; NCI Probably Will Reject Any Further Delay

October 15, 1976

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009